Editor-in-Chief

Jianfei Yang

Jianfei Yang
Editor-in-Chief
Department of Immunology, GlaxoSmithKline Pharmaceuticals Ltd
USA

Biography

Dr. Jianfei Yang is a principal scientist, project leader and immunologist at Tempero, GlaxoSmithKline, in Cambridge, MA, USA. He received a PhD in Pathology from Niigata University in Japan. He then obtained postdoctoral training in Dr. Ken Murphy’s lab at HHMI and Washington University. In the past 18 year, he has been studying the role of CD4+ T helper cells in immunity and diseases. He has 14 years of experience in immuno-inflammatory disease research and pharmaceutical drug development. He has published numerous papers and patents. He has been recognized as an expert in Th17 research and drug development in pharmaceutical industry.

Research Interest

Research interests include the role of immune cells such as Th17 and Treg cells in innate and protective immunity, autoimmune and inflammatory diseases, and cancers. He is interested in drug discovery of small molecule and novel therapeutic monoclonal antibodies for the treatment of various diseases. He is also interested in immunotherapy for tumor and inflammatory diseases.

Ramon Cacabelos

Ramon Cacabelos, MD, PhD, DMSc
Editor-in-Chief
Professor & Chairman, Department of Biotechnology and Genomics
EuroEspes Biomedical Research Center, Continental University Medical School, Spain

Biography

Dr. Ramón Cacabelos is Professor and Chairman of Genomic Medicine and President of the International Center of Neuroscience and Genomic Medicine EuroEspes, Corunna, Spain. He received his M.D. from Oviedo University, Oviedo, Spain; Ph.D. from Santiago University, Santiago de Compostela, Spain; and D.M.Sci. (Psychiatry) from Osaka University Medical School, Osaka, Japan. After a decade at the Department of Psychiatry in Osaka, he returned to Spain and focused his research activity on the genomics, epigenomics, and pharmacogenomics of brain disorders, with special emphasis on neurodegenerative disorders (Alzheimer’s disease, Parkinson’s disease). He has published over 700 papers and 30 books and is Editor-in-Chief of the first World Guide for Drug Use and Pharmacogenomics and President of the World Association of Genomic Medicine.

Research Interest

Psychiatry/Basic and Clinical Neurosciences, Neurogerontology & Neurogeriatrics, Drug Use and Pharmacogenomics.

Ammar Mohammed Hamood AL-Farga

Ammar Mohammed Hamood AL-Farga
Editor-in-Chief
Assistant Professor
University of Jiangnan, P.R. China

Biography

Biochemistry

Research Interest

Food Science and Biochemistry